Our environmental footprint
We strive to improve our environmental performance as well as the performance of others within our sphere of influence. By this, we mean the protection of land, water, air, natural resources, and biodiversity.
Our environmental and climate-related impact comprises direct and indirect impacts, through sourced activities both upstream and downstream and through activities caused by the company’s operations.
Our carbon footprint is caused by energy consumption in pharmaceutical manufacturing, business travel, supply chain logistics, and the distribution of medicines. Environmental impacts from production and laboratories are mainly due to the use of energy, water and chemicals, waste generated, and discharge of sewage.
Our greenhouse gas (GHG) emissions in tonnes CO2e
|
Scope 1 |
Direct emissions from our own operations |
|
904 |
|
Scope 2 |
Indirect emissions from our own operations |
|
648 |
|
Total emissions Scope 1 & 2 |
|
1,551 |
|
|
Scope 3 |
Other indirect emissions that occur in our value chain |
|
124,565 |
Reducing the environmental footprint
Our direct and indirect emissions (scope 1 and scope 2) are limited and occur from commercial operations in 30 country units as well as the biological production facility in Stockholm, Sweden, the legacy laboratory in Geneva, Switzerland, as well as our car fleet.
We track our emissions in a common reporting platform that includes all global operations and entities. All electricity consumed at our Stockholm manufacturing facility originates from certified renewable energy sources. By reducing energy consumption, increasing efficiency, and switching to renewable energy, we aim to achieve net zero emissions from our sites and car fleet no later than 2030.
We have mapped and identified relevant scope 3 categories, other indirect emissions that occur in our value chain, and data connected to these categories has been gathered and calculated. All the production of commercial medicines is outsourced to contract manufacturers. We have obtained limited emission data from contract manufacturers. The use of supplier specific data will be gradually expanded to include all major contract manufacturers and transport and logistics partners.
Waste
We strive to continually increase data collection on waste and thereby enable continual reductions in waste volumes wherever possible. Measures are also taken to minimise the generation of waste. In Sweden, we have an established process for the reuse and recycling of our unwanted IT equipment via a certified technology life cycle management service partner. This process is being rolled out to Sobi’s operations worldwide, including the training of local teams.
Environmental management
Our Environmental policy states the principles and defines roles and responsibilities for managing environmental issues within all our operations, including affiliates and subsidiaries as well as Sobi’s sphere of influence. It emphasises our commitment to complying with applicable laws and regulations, a proactive approach to protecting land, water, air, climate, natural resources, and biodiversity, and a commitment to risk reduction and transparency.